Capital's Great Migration: From a $55B Gaming Buyout to the Hard Tech BoomGlobal Report·3 hours agoEA+3.00%MRCY-2.89%
The Fringe of the 2026 Market: Where the Real Weirdness HappensGlobal Report·3 hours agoMRCY-2.89%LDOS+1.64%
Zevra Therapeutics (ZVRA) Following EMA Setback Is The Sell Off A Valuation GapSimplywall·1 day ago, 04:24 AMZVRA-23.92%
Navigating Cross-Border Currents: Sector Divergence and Strategic Pivots in a Fragmented 2026 MarketGlobal Report·1 day ago, 04:13 AMGNRC-4.03%TGTX+0.97%
Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Given Average Rating of "Moderate Buy" by AnalystsMarket Beat·1 day ago, 01:14 AMZVRA-23.92%
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga_article·2 days ago, 07:05 AMZVRA-23.92%RADX-17.25%
Zevra Therapeutics Provides Update on Regulatory Submission for Arimoclomol for the Treatment of Niemann-Pick Disease Type C (NPC) in the European Union | ZVRA Stock NewsStockTitan·2 days ago, 10:30 PMZVRA-23.92%
